search icon
  • Print
  • ShareThis
  • Text Size
  • IDSA
  • IDSA Statement on the President’s Fiscal Year 2018 Budget Proposal

    05/23/2017


    The Infectious Diseases Society of America urges Congress to reject the short-sighted and destructive approach to research and public health evidenced in the Trump administration’s proposed budget for 2018.  

    Proposed cuts amounting to $1.2 billion overall cut to the Center for Disease Control and Prevention’s programs when outbreaks of hepatitis C and HIV fueled by the opioid epidemic, as well as tuberculosis, syphilis and measles threaten public health is dangerous and misguided. In addition, the Trump administration’s proposal would shift CDC’s antimicrobial resistance dollars to the Prevention and Public Health Fund, which the Administration and Congress are seeking to repeal, threatening recent progress toward prevention and detection of infections resistant to current treatments. The massive cuts to domestic and global public health and research efforts included in the plan will gravely limit the effectiveness of what would otherwise be positive aspects of the proposal – the establishment of a new federal fund for outbreak responses the maintenance of support for the Biomedical Advanced Research and Development Authority, and the additional funding for Zika and other vector-borne diseases preparedness -- all of which IDSA supports.

    The White House proposal to slash the National Institutes of Health budget by $7.2 billion comes as current news reports -- of a domestic outbreak of treatment resistant fungal infections, and of a new emerging Ebola outbreak in the Democratic Republic of Congo -- highlight the recklessness of cutting funding to the National Institute of Allergy and Infectious Diseases and the Office of AIDS Research, and of eliminating the Fogarty International Center that supports research and capacity building to protect health at home and abroad. Cutting the NIH budget by 21 percent also would endanger a major economic engine in communities across the country, reverse efforts to attract and retain young physician-scientists, and halt work to develop urgently needed new antibiotics, as well as improved HIV treatments, a vaccine, and ultimately a cure.

    The administration’s proposed cuts to global health programs will jeopardize efforts to end HIV as a worldwide public health threat, diminish needed resources to address drug-resistant tuberculosis and endanger domestic health security by reducing resources to detect, prevent and respond to infectious disease threats where they originate. The overall global health allocation for USAID is $1.51 billion which represents a devastating 51 percent cut below FY2017 funding. Additionally, PEPFAR is funded at $470 million below FY2017 funding, and the Global Fund is cut by $225 million.

    IDSA is encouraged by longstanding bipartisan support in Congress for federal programs and funding that support the prevention, diagnosis and treatment of infectious diseases. We will continue to analyze the President’s budget request, and present our case to Congress for U.S. leadership in domestic and global infectious disease responses as we continue to advocate for robust funding for biomedical research and public health.

| IDSA | Contact Us

© Copyright HIVMA 2017 HIV Medicine Association

Full Site Mobile Site